Integrated Proteins Limited held a Board of Directors meeting on Thursday, 5th November 2026 at their registered office in Jamnagar. The meeting commenced at 18:30 HRS (IST) and concluded at 20:00 HRS (IST).
The Board approved the Unaudited Financial Results for the Quarter and half year ended on 30th September, 2026 along with the Limited Review Report by the auditors. This disclosure is made in compliance with Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Results Highlights (Standalone, Rs. In Lakh)
Quarter Ended September 30, 2026:
- Revenue From Operations: ₹399.60
- Other Income: ₹0.50
- Total Revenue: ₹400.10
- Cost of materials consumed: ₹388.51
- Employee benefit expense: ₹0.67
- Depreciation and amortisation expense: ₹3.03
- Total expenses: ₹392.21
- Profit Before Tax: ₹7.89
- Tax Expense - Current Tax: ₹1.99
- Net Profit for the Period: ₹5.90
- Basic EPS: ₹0.03
- Diluted EPS: ₹0.03
Quarter Ended September 30, 2025 (Comparative):
- Revenue From Operations: ₹419.82
- Total Revenue: ₹419.82
- Cost of materials consumed: ₹404.45
- Employee benefit expense: ₹1.35
- Depreciation and amortisation expense: ₹5.22
- Total expenses: ₹413.10
- Profit Before Tax: ₹6.72
- Tax Expense - Current Tax: ₹1.69
- Net Profit for the Period: ₹5.03
- Basic EPS: ₹0.16
- Diluted EPS: ₹0.16
Half Year Ended September 30, 2026:
- Revenue From Operations: ₹1,454.33
- Other Income: ₹2.15
- Total Revenue: ₹1,456.48
- Cost of materials consumed: ₹1,389.61
- Employee benefit expense: ₹1.69
- Depreciation and amortisation expense: ₹8.84
- Total expenses: ₹1,400.14
- Profit Before Tax: ₹56.34
- Tax Expense - Current Tax: ₹14.18
- Deferred Tax Liabilities: ₹42.16
- Net Profit for the Period: ₹42.16
- Basic EPS: ₹0.23
- Diluted EPS: ₹0.23
Half Year Ended September 30, 2025 (Comparative):
- Revenue From Operations: ₹419.82
- Other Income: ₹4.72
- Total Revenue: ₹424.54
- Cost of materials consumed: ₹404.45
- Employee benefit expense: ₹2.03
- Depreciation and amortisation expense: ₹9.26
- Total expenses: ₹417.81
- Profit Before Tax: ₹6.73
- Tax Expense - Current Tax: ₹1.69
- Deferred Tax Liabilities: ₹5.04
- Net Profit for the Period: ₹5.04
- Basic EPS: ₹0.16
- Diluted EPS: ₹0.16
Capital Structure
- Paid-up equity share capital: ₹1,871.36 lakh (consistent across periods)
- Face value per share: ₹10.00
- Reserves as of previous year: ₹223.10 lakh (30-09-2026), ₹217.56 lakh (30-06-2026), (₹29.39) lakh (30-09-2025)
Additional Information
- The financial results were reviewed by the Audit Committee and approved by the Board of Directors
- Results prepared in accordance with Indian Accounting Standard (Ind AS) 34 - Interim Financial Reporting
- Segment reporting not required as the company has no reportable business segments
- Figures for corresponding previous periods have been regrouped/reclassified for comparability
- Statement of Assets and Liabilities and cash flow statement as on 30th September 2026 are enclosed
Assets and Liabilities (as of 30th September, 2026)
- Total Assets: ₹2,504.01 lakh
- Trade receivables: ₹56.58 lakh
- Cash and cash equivalents: ₹1.05 lakh
- Other current assets: ₹2,427.83 lakh
- Equity: Share capital ₹1,871.36 lakh + Other Equity ₹234.70 lakh
- Current liabilities: Short Term Borrowings ₹386.12 lakh, Trade payables ₹0.56 lakh, Provisions ₹20.40 lakh
Cash Flow Statement (Half Year Ended September 30, 2026)
- Net cash used in operating activities: ₹(677.21) lakh
- Net cash from investing activities: ₹1.15 lakh
- Net cash from financing activities: ₹388.12 lakh
- Net increase in cash: ₹1.21 lakh
- Cash equivalents at beginning: ₹(1.56) lakh
- Cash equivalents at end: ₹1.05 lakh
Segment Information
The company operates primarily in Agro & Trading segment which contributed:
- Q2 FY27 Revenue: ₹399.60 lakh
- H1 FY27 Revenue: ₹1,450.83 lakh
- Q2 FY27 Segment Profit: ₹11.08 lakh
- H1 FY27 Segment Profit: ₹51.53 lakh
Other segments include Textile, Securities, Medical, and Real Estate with minimal contributions.